L-arginine, the precursor of endogenous nitric oxide (NO), has been shown to enhance endothelial function and to reduce the progression of atherosclerosis in cholesterol-fed rabbits. In the present study, we investigated whether myointimal cell proliferation is enhanced in hypercholesterolaemic rabbit aorta and whether chronic treatment of the rabbits with L-arginine or with the NO synthase inhibitor L-NAME influences this proliferative response and vascular monocyte accumulation. Rabbits were fed 1% cholesterol or normal rabbit chow for 12 weeks. Subgroups of cholesterol-fed rabbits were treated with oral L-arginine (2.25%) or L-NAME (3 mg/dl) in drinking water. Myointimal cell proliferation was quantified in aortic segments by immunohistochemical detection of bromodeoxyuridine (BrdU) incorporation into nuclear DNA; vascular monocyte accumulation was assessed by immunohistochemistry using a monoclonal anti-macrophage/monocyte antibody (RAM-11). Plasma levels of L-arginine and the endogenous NO synthase inhibitor, ADMA, were quantified by high-performance liquid chromatography (HPLC). Cholesterol feeding increased the aortic intima/media (I/M) ratio, which was not measurable in the control group, to 1.9 9 0.3. This was paralleled by enhanced cell proliferation (cholesterol, 2.4 9 0.2%; PB 0.05; control, 0.02 90.001% BrdU-positive cells per 72 h) and vascular monocyte accumulation. Double immunostaining for BrdU and h-actin showed that about two thirds of the proliferating cells were smooth muscle cells. ADMA levels increased from 0.8 90.1 vmol/l to 2.2 9 0.2 vmol/l in cholesterol-fed rabbits, but were unchanged by L-arginine or L-NAME treatment. Myointimal proliferation and intima/media ratios were correlated with ADMA plasma levels. Dietary L-arginine reduced monocyte accumulation by 85 9 2% (PB 0.05 vs cholesterol), myointimal cell proliferation (1.8 90.3% per 72 h; PB 0.05) and intimal thickening (I/M ratio: 0.7 9 0.2), whereas the inhibitor of NO synthase, L-NAME, further increased cell proliferation to 3.1 90.4% per 72 h (PB 0.05). No significant difference was observed in vascular monocyte infiltration between the cholesterol and L-NAME groups. We conclude that cell proliferation and vascular monocyte accumulation are enhanced in hypercholesterolaemic rabbit aorta. These atherogenic effects can be attenuated by dietary L-arginine. Decreased NO formation might underlie the enhanced monocyte accumulation and cell proliferation in hypercholesterolaemic rabbit aorta. The observed inhibition of cell proliferation adds to our understanding of the antiatherosclerotic effects of L-arginine in vivo.
Introduction
Endothelial dysfunction is a well known feature of atherosclerotic arteries [1] . It is related to a decreased biological activity of nitric oxide (NO) produced by the endothelium from the terminal guanidino nitrogen of the amino acid precursor L-arginine [2] . The lack of NO has been shown to be involved in impaired vasorelaxation [3] , enhanced platelet aggregation [4] and leukocyte adhesion [5] . Exogenous NO has further been shown to inhibit smooth muscle cell proliferation in vitro via a cGMP-dependent mechanism [6, 7] . Endothelium-dependent relaxations in cholesterol-fed rabbit aortae are partly restored by chronic oral administration of L-arginine [8, 9] . In a previous study, we demonstrated that this effect was brought about by restoring systemic NO production, as assessed by increased urinary NO 3 − excretion rates in vivo and by reducing the enhanced release of superoxide anions from the hypercholesterolaemic vascular wall [10] . Superoxide anions inactivate NO [11] and promote leukocyte adhesion [12] . In atherosclerosis, adhesion of monocytes to the endothelium is enhanced [13] . Dietary supplementation of hypercholesterolaemic rabbits with L-arginine attenuates the endothelial adhesiveness for mononuclear leukocytes [14] . Leukocytes may therefore contribute to the progression of atherosclerosis by releasing cytokines and growth factors which, in turn, stimulate a proliferative response in the arterial wall and thereby promote intimal thickening and vascular occlusion [15] .
Using incorporation rates of 5%-bromodeoxyuridine, a thymidine analogue which is incorporated into nuclear DNA during the S-phase of the cell cycle, as a marker for DNA synthesis rates, it has been shown that experimental angioplasty induces a strong proliferative response of myointimal cells [16] , leading to intimal hyperplasia and restenosis. Chronic dietary supplementation with L-arginine has been shown to reduce the extent of intimal thickening after experimental angioplasty in rabbits [17, 18] , as well as the monocyte accumulation associated with this vascular injury [19] . An increased intima/media ratio has also been found in aortae from cholesterol-fed rabbits without prior balloon angioplasty [10, 20] . Cell proliferation contributes to this intimal thickening process [21, 22] , but it is not known whether L-arginine decreases myointimal proliferation and monocyte accumulation induced by biochemical injury of the vascular wall in vivo. Some of the pathophysiological changes in NO activity in hypercholesterolaemic rabbits may be caused by accumulation of asymmetric dimethylarginine (ADMA), an endogenous, competitive inhibitor of NO synthase [23, 24] .
Therefore, the present study was undertaken to investigate whether monocyte accumulation and myointimal cell proliferation contribute to intimal thickening in hypercholesterolaemic rabbits. We also studied whether chronic treatment with L-arginine or with NO synthase inhibitor (L-NAME) affects these reactions in the atherosclerotic aortic wall in vivo.
Material and methods

Study design
Twenty-eight male New Zealand white rabbits, weighing 2.5-3.0 kg, were studied for 12 weeks. The study protocol conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication No. 85-23, revised 1985) and had been approved by the local supervisory committee for studies in animals at Hannover. Animals were housed individually and water was provided ad libitum. After 2 weeks of adaptation, rabbits were separated into four groups: Three groups of eight rabbits were fed rabbit chow enriched with 1% cholesterol (Altromin), four rabbits received normal rabbit chow and plain tap water (control group). The rabbits from one of the cholesterol-fed groups received 2.25% L-arginine (Sigma) in drinking water throughout the study (cholesterol+ L-arginine group), a second group received L-NAME (Sigma) in drinking water (3 mg/100 ml; cholesterol +L-NAME group) and the third group received plain tap water (cholesterol group). Plasma samples were collected at the beginning and at the end of the study period. After 12 weeks of dietary intervention, the rabbits were anaesthetized with sodium pentobarbital (10 mg/kg of body weight) and an arterial catheter was placed in the descending aorta via the femoral artery. After blood pressure recording, the animals were sacrificed and the thoracic aorta and carotid arteries were removed. The thoracic aorta was dissected free of adhering adipose and connective tissue and segments were prepared for immunohistochemistry and for isometric tension recording as described below. Care was taken to ensure that corresponding segments were used for the same types of analyses from all animals. The carotid arteries were dissected free of adhering connective tissue and opened longitudinally for morphometric analysis of the intimal surface.
Determination of plasma L -arginine, dimethylarginine and cholesterol concentrations
Plasma levels of L-arginine and dimethylarginines were determined by high-performance liquid chromatography (HPLC) using pre-column derivatization with o-phthalaldehyde and fluorescence detection as described previously [23] . Plasma total cholesterol was determined by a commercial immunofluorescence assay system (TDX; Abbott).
Immunohistochemical and morphometric analyses
To determine the fraction of cells in the arterial wall undergoing DNA replication, 5%-bromodeoxyuridine (BrdU; Sigma), was given to each animal, 72, 48 and 24 h before excision of the aorta. BrdU was applied at a dose of 100 mg/kg of body weight, of which two thirds were injected intraperitoneally and one third was given as a subcutaneous neck depot. In preliminary studies, this method of application of BrdU has been shown to produce a specific staining of proliferating cells within the arterial wall ( [20, 26] , R.H. Bö ger and S. Kienke, unpublished results). Estimation of the small intestine mucosa-labeling index had been used in preliminary experiments to control BrdU incorporation into replicating cells as described by Hanke et al. [16] .
Sections of the excised aortae were embedded in poly-L-lysine (Sigma) and prepared for immunohistochemical and morphometric analysis. Incorporation of BrdU was assessed in semi-thin cross sections using a monoclonal antibody directed against BrdU (1:50, Becton-Dickinson, 30 min), after partial denaturation of DNA with formamide. Immunohistochemical detection was performed using a secondary, alkaline phosphatase-conjugated antibody (Sigma) and the alkaline phosphatase reaction with naphthol -phosphate and fast blue BB salt (Serva) as substrate, as described by Westermann et al. [26] . In four sections from each rabbit, the number of cells having incorporated BrdU into their nuclear DNA was counted and expressed as a percentage of the total number of intimal cells in each slice.
Monocyte immunostaining was performed in adjacent sections using a monoclonal antibody against rabbit monocytes/macrophages (mouse-anti-rabbit monoclonal antibody RAM-11; Dako), as described by Tsukada et al. [27] , using an acid phosphatase-coupled secondary anti-mouse antibody and the peroxidase reaction. As individual monocytes are difficult to distinguish within the vascular wall with this technique, microdensitometric analyses for semiquantitative evaluation of the intensity of immunostaining were performed with a computer-assisted video imaging system as previously described [28] . A similar index has previously been used by others to assess monocyte accumulation in the vascular wall after experimental balloon angioplasty [19] . Three series of sections were stained with one section per animal in each series and the staining indices were averaged for each animal in order to minimize interindividual variability due to the staining procedure. The areas and optical densities of stained areas within the vascular wall were measured and background gray level was subtracted. The values obtained were expressed as relative density and represented the specific staining due to the immunohistochemical reaction.
To determine whether the proliferating cells were smooth muscle cells or monocytes/macrophages, double staining was performed in additional sections of subgroups of rabbits using the monoclonal anti-BrdU antibody and either a monoclonal antibody against h-actin (anti h-actin monoclonal antibody clone 1A4, Sigma, Munich, Germany) or the RAM-11 monoclonal antibody directed against monocytes/macrophages. Fluorescein-coupled secondary antibodies were used in these experiments and the sections were analyzed using double fluorescence microscopy. The fraction of BrdU-positive cells staining for h-actin or for the monocyte surface antigen was counted and expressed as a percentage of the total number of BrdU-positive cells.
Measurements of intimal and medial cross-sectional areas were made on adjacent sections stained with haematoxylin-eosin using a semiautomatic planimetric system (Zeiss) [29] . Four sections from each animal were analyzed and the values were averaged.
The proximal common carotid arteries were dissected free of adventitial tissue and rinsed free of any remaining blood. Thereafter, the arteries were dissected longitudinally and placed on an even surface for photography of intimal lesions. Photographs were digitalized and measurements of total intimal area and plaque area were made by planimetry of the photographic images.
All histomorphological measurements were performed by skilled observers (S. Kienke, A.C. Stan, R. Nafe) blinded to the treatment groups.
Isometric tension recording
Rings of thoracic aorta (3-4 mm long) were placed into organ baths filled with oxygenated (95% O 2 , 5% CO 2 ) modified Krebs solution (37°C, pH 7. For 60 min the rings were gradually stretched to a resting tension of 2 g, previously determined to be the optimum of their length-tension relationship and repeatedly washed with fresh Krebs solution. The rings were then precontracted with noradrenaline (1 vM) and relaxed with acetylcholine (1 vM) for testing of endothelial integrity, as described previously [10] . All rings from control animals showed more than 70% relaxation to acetylcholine. After wash-out, cumulative concentration response curves were obtained with the endothelium-dependent vasodilator acetylcholine and the endothelium-independent vasodilator sodium nitroprusside (each 1 nM to 0.1 mM). Relaxations were expressed as a percentage of the precontractile tension induced with 1 vM noradrenaline.
Calculations and statistics
All values are given as means9S.E.M. Statistical significance was tested using unpaired, two-tailed t-test for comparisons between groups and by analysis of variance for repeated measures followed by the Scheffé f-test for treatment effects within groups. Statistical significance was accepted at the 0.05 level of probability.
Results
Physiological and biochemical measurements
Blood pressure was not significantly different in the control, cholesterol and cholesterol+L-arginine groups (104.49 5.5/74.5 99.4 mmHg), but it was significantly elevated by dietary L-NAME (122.894.0/90.0 9 4.7 mmHg; PB 0.05).
Baseline plasma L-arginine levels were 87.298.8 vmol/l. They were increased to 180 -240 vmol/l by L-arginine administration (P B0.05) and remained unchanged in all other groups. The plasma concentrations of the endogenous NOS inhibitor ADMA and its biologically inactive, symmetric stereoisomer (SDMA) were 0.89 0.1 vmol/l and 0.890.1 vmol/l in the control group. They were increased to 2.29 0.2 vmol/l and 2.1 9 0.2 vmol/l in the cholesterol group, respectively (each P B0.05 vs control). Treatment with L-arginine or L-NAME did not significantly influence plasma ADMA (2.2 9 0.2 and 2.3 9 0.4 mmol/l) or SDMA levels (2.290.3 and 2.49 0.3 vmol/l).
Neither L-arginine nor L-NAME had any influence on plasma total cholesterol levels, which were 29.09 1.4 mg/dl at baseline and were elevated to 799.3933.0 mg/dl by cholesterol feeding (Table 1) . 
Morphometric and immunohistochemical analyses
No plaques were detected in carotid arteries from control rabbits. In contrast, intimal plaque area represented 42.2 9 9.0% of the total intimal area in the cholesterol group. L-NAME did not significantly change intimal plaque area (45.69 4.8%; P= NS vs cholesterol). In contrast, L-arginine significantly decreased intimal plaque area to 9.29 4.1%. Intimal plaque area in this group was significantly different from the cholesterol group (PB0.05), but not from the control group (Fig. 1) .
Aortic intimal cross sectional area was zero in control rabbits, as only the endothelial cell monolayer was present in these segments. In contrast, a significant intimal thickening was observed in all rabbits fed cholesterol (each PB 0.05 vs control; Fig. 2 ). The medial area was also slightly, but significantly, larger in cholesterol-fed animals as compared to controls (Table  2) . Supplementation with L-arginine significantly decreased intimal area and intima/media ratio (by 63.2 9 3.8%; PB 0.05), while administration of L-NAME did not induce a further, significant increase in intima/media ratio as compared to the cholesterol group (Fig.  3a) . Intima/media ratios were significantly correlated to plasma ADMA levels in individual rabbits (R=0.60; PB 0.01; Fig. 3b ). Fig. 4 shows original photomicrographs from aortic cross sections stained for BrdU. Very sparse immunohistochemical staining for BrdU was found in aortic sections from control rabbits. Myointimal proliferation Light microscopy showed that the intimal thickening was due to accumulation of monocytes and smooth muscle cells, with only little interstitial material, such as collagen fibrils, between them. Some aortae with the maximal degree of intimal thickening also presented calcifications at the intima -media boundary. Monocyte immunostaining confirmed that cholesterol feeding significantly increased the infiltration of the thickened intima with mononuclear leukocytes (Fig. 6) . Dietary L-arginine significantly reduced the monocyte accumulation index by 85 94% (P B0.05), whereas there was no significant difference in monocyte infiltration between the cholesterol and L-NAME groups (Fig. 7) .
Using double immunofluorescence staining against BrdU and h-actin or monocyte surface antigen, 50-60% of proliferating cells were identified as smooth muscle cells, whereas only 20 -25% of proliferating cells also stained for the monocyte surface antigen (Fig. 8). 
Endothelium-dependent 6ascular relaxation
Endothelium-dependent relaxation in response to acetylcholine was significantly and almost completely impaired in cholesterol-fed rabbits. Treatment with L-NAME had a slight additional inhibitory effect; indeed, small contractions were evoked by the higher concentrations of acetylcholine in aortic rings from L-NAMEtreated rabbits (Fig. 9a) . Dietary supplementation with L-arginine resulted in a significant restoration of endothelium-dependent relaxation. There was a negative linear correlation between the maximal relaxation induced by acetylcholine, a measure of the biological activity of NO and the myointimal proliferation rate in adjacent aortic cross-sections from the same animal (R= 0.59, PB 0.01).
Discussion
The present paper shows that hypercholesterolaemia is associated with vascular monocyte accumulation and enhanced myointimal proliferation in rabbits. These changes are related to elevated levels of the endogenous NO synthase inhibitor ADMA. Chronic oral administration of L-arginine decreases myointimal cell proliferation, decreases intimal plaque area and intima/media ratio and reduces accumulation of monocytes in the vascular wall, as compared to cholesterol-fed animals. In contrast, administration of the NO synthesis inhibitor L-NAME further increased myointimal proliferation and completely abolished endothelium-dependent relaxation.
Cholesterol feeding induces intimal thickening and impairs endothelial NO elaboration in rabbits [10, 20] . Dietary L-arginine has been shown to restore the biological functions of NO in hypercholesterolaemic rabbits, leading to enhanced endothelium-dependent vascular relaxation [8, 9] . Moreover, Cooke et al. [20] and Jeremy et al. [30] found that L-arginine administration reduced plaque formation and intimal thickening in cholesterol-fed rabbits. In the present study, we found similar effects of L-arginine, in that L-arginine significantly reduced intimal plaque area in the carotid arteries and reduced intimal cross-sectional area in the thoracic aorta. These results confirm observations made earlier by others on the effects of L-arginine on balloon angioplasty-induced vascular injury [17] [18] [19] . However, in the present paper hypercholesterolaemia was the only 'injury' applied to the vascular wall. The relatively small effect we observed after treatment with L-NAME may be accounted for by the relatively small dose of L-NAME we used, as Naruse et al. [31] found, a significant promotion of atherosclerotic lesions in the thoracic aortae of hypercholesterolaemic rabbits with a 2-fold higher dose of L-NAME. We chose the smaller dose of L-NAME to avoid any deleterious hemodynamic effects of L-NAME during its chronic application. Blood pressure recordings at the end of the study period showed that the dose chosen by us was hemodynamically active. Moreover, the relatively small inhibitory effect of L-NAME on endothelium-dependent relaxation may indicate that NO formation was already submaximally reduced by the high cholesterol diet alone, leaving little residual NO activity to detect additional inhibitory effects of L-NAME. Elevated ADMA plasma levels may have caused reduced NO formation in this study, as we have previously reported that the plasma concentrations of ADMA are elevated in cholesterol-fed rabbits and this elevation is related to reduced urinary nitrate excretion [23, 24] . It has been known that cell proliferation is a key event in the atherogenic process since the demonstration by McMillan and Duff in 1948 [21] of mitotic figures in aortic lesions of cholesterol-fed rabbits. More recent studies using [ 3 H]thymidine incorporation have confirmed that DNA synthesis occurs within arterial lesions [22, 32] . BrdU incorporation has been used for detecting and quantitating the fraction of proliferating cells in various tissues [33] , including the vascular wall [34] . With this technique, it has been shown that in normal rabbit aortae there is only a very small fraction of cells undergoing proliferation [16] . Mechanical injury to the vascular wall by experimental angioplasty induces a significant, transient increase in myointimal proliferation [16, 25] , reaching a maximal proliferation rate of some 8-12% per 24 h 1 week after the injury.
The present paper shows that 'biochemical injury' induced by hypercholesterolaemia per se, stimulates myointimal cell proliferation in the vascular wall, resulting in intimal hyperplasia and luminal narrowing. The proliferation rate we found after 12 weeks of cholesterol feeding was much lower (2.490.2% per 72 h) than that reported after mechanical injury. However, we do not know the time course of the proliferative response during the induction of hypercholesterolaemia. Proliferation rates may have been higher at an earlier stage of the atherogenic process. Indeed, Rosenfeld and Ross recently showed higher proliferative activities in early, as compared to late, atheromatous lesions [35] . The present paper extends these findings by demonstrating for the first time that the proliferative response in the vascular wall to hypercholesterolaemia is modulated by L-arginine in vivo.
Endothelial cells inhibit vascular proliferative responses in vitro by releasing a soluble, anti-proliferative factor, as vascular smooth muscle cells co-cultured with endothelial cells show less proliferative activity than smooth muscle cells cultured alone [36] . Our previous observation that dietary L-arginine enhances the urinary excretion rate of nitrate, the final metabolite of NO, in hypercholesterolaemic rabbits [10] provides further evidence that this factor may be identical with NO. In the present paper, myointimal proliferation and intimal thickening are associated with the plasma levels of the endogenous NOS inhibitor ADMA. Furthermore, a recent study by von der Leyen et al. [37] demonstrated that in vivo gene transfer of the endothelial NOS gene into the lesion area after experimental angioplasty, restored endothelial NO production and resulted in reduced myointimal thickening. Dietary L-arginine also reduced cell proliferation in remnant glomeruli after renal ablation (as assessed by quantifying the expression of proliferating nuclear antigen, PCNA) [38] . Moreover, the exogenous NO donor SIN-1 has been shown to reduce smooth muscle cell proliferation (as assessed by immunohistochemical detection of PCNA) after experimental angioplasty [39] . Double immunostaining showed that the majority of cells undergoing DNA synthesis within the thickened intima were smooth muscle cells and a smaller subset of proliferating cells could be identified as monocytes/ macrophages. This is in concurrence with previous findings that most proliferating cells within atherosclerotic lesions are smooth muscle cells [35] . Rosenfeld and Ross identified 30% of the [ 3 H]-labeled cells within the aortic walls of cholesterol-fed rabbits as macrophages, using the same monoclonal antibody as in the present study [35] . The detection of proliferating macrophages within the atherosclerotic vascular wall shows that the presence of macrophages within lesions is not entirely due to adhesion and infiltration of circulating monocytes, but that macrophages resident within the lesions are able to contribute to the continued expansion of the intima. Although due to logistical reasons we were not able to exactly quantify the effects of dietary L-arginine and L-NAME on the proliferative response of the different cellular components of the lesions in all animals, it appeared that dietary L-arginine mainly reduced the proliferative response of smooth muscle cells. In addition to the restoration of endothelium-dependent vasodilator function by L-arginine [8] [9] [10] and its inhibitory effect on the endothelial adhesion of monocytes [14] , inhibition of smooth muscle cell proliferation may be another important mechanism contributing to its antiatherosclerotic effects [40] . Immunohistochemical staining for mononuclear leukocytes using a monoclonal antibody raised against rabbit monocytes/macrophages (RAM-11), followed by the acid phosphatase reaction. Please note that the intima thickening in the L-arginine-treated rabbit is not representative for this group. Original magnification × 20. Fig. 7 . Myointimal mononuclear leukocyte accumulation index in rabbit aortic cross sections. For the identification of groups, refer to Fig. 1 Values represent mean 9 S.E.M. of two measurements per rabbit. *, PB 0.05 vs cholesterol. Fig. 8 . Double immunofluorescence staining of hypercholesterolaemic rabbit aortic cross sections using monoclonal antibodies directed against BrdU and h-actin (a), or against BrdU and monocyte surface antigen (b). Nuclei having incorporated BrdU appear blue, the h-actin and monocyte stainings gave a red fluorescence. Note that the proliferative activity and smooth muscle cells are mainly located near the lumen of the aorta, whereas monocytes/macrophages are mainly found in deeper parts of the thickened intima. The luminal side of the vessel wall is directed to the right in both panels. M, media; I, intima.
It is not clear whether the inhibitory effect of Larginine on cell proliferation is mediated by a direct action on proliferating vascular smooth muscle cells and macrophages, or whether it is a phenomenon secondary to the reduced monocyte accumulation in the vascular wall. The magnitude of the effects induced by L-arginine in the present study suggests that the proproliferative effects of leukocyte-derived cytokines and growth factors on the vascular wall may be diminished by L-arginine. Tsao et al. [14] recently demonstrated that dietary L-arginine reduces monocyte adhesion to the endothelium from hypercholesterolaemic rabbits, thus interfering with one of the earliest steps in atherogenesis. The contrary effect is induced by NO synthase inhibition [41] . The inhibitory effect of L-argininederived NO on monocyte adhesion may be mediated independently of cGMP, as NO has been shown to decrease the endothelial expression of adhesion molecules, possibly via reducing oxidative stress [42, 43] . Furthermore, there may be direct inhibition of vascular smooth muscle cell proliferation by L-arginine-derived NO. NO has been shown to exert a direct, cGMP-mediated inhibition of cell proliferation [6, 7] and DNA synthesis [44] in cultured smooth muscle cells in vitro.
Whether enhanced NO formation during L-arginine administration is predominantly due to the activity of the constitutive endothelial NO synthase or the inducible isoform remains unclear. In the presence of elevated levels of the endogenous, competitive NOS inhibitor ADMA, the K m of the NOS III may be shifted to a concentration range in which exogenous L-arginine influences NOS activity ( [40] and unpublished data). Moreover, the inducible NO synthase isoenzyme is expressed in the atherosclerotic vascular wall [45] . However, the enzymatic origin of NO may not be very important, as Yan et al. [46] have recently demonstrated that NO generated by the inducible NO synthase in arteries injured by experimental angioplasty also contributes to the maintenance of vascular vasodilator tone and inhibition of platelet aggregation.
Bellas et al. [47] have recently shown that a constitutive NF-sB-like activity is essential for the proliferation of vascular smooth muscle cells in culture. Endothelial NO may downregulate this proliferative activity by reducing vascular oxidative stress [48] and thereby interfering with the redox-mediated activation of NF-sB [42, 43] . We have recently shown that dietary supplementation with L-arginine reduces the vascular elaboration of superoxide radicals, thereby providing direct evidence for reduced oxidative stress within the atherosclerotic vascular wall during L-arginine supplementation [10] . These results may explain the finding of Singer et al. [49] that L-arginine supplementation more strongly affects vascular structure than vascular function in cholesterol-fed rabbits.
In conclusion, we have demonstrated for the first time that dietary L-arginine exerts an antiproliferative effect in the hypercholesterolaemic rabbit vascular wall in vivo. By contrast, chronic inhibition of NO synthesis by L-NAME further enhanced myointimal proliferation and the proliferative response was negatively correlated to maximal endothelium-dependent relaxation and to the accumulation of the endogenous NOS inhibitor ADMA. Reduced monocyte adhesion and accumulation in the vascular wall may explain in part this effect, although a direct antiproliferative action of L-arginine on smooth muscle cells may also be involved. Fig. 9 . Endothelium-dependent relaxation induced by acetylcholine in isolated aortic rings from rabbits fed normal rabbit chow (control), or a diet enriched with 1% cholesterol (cholesterol), or a cholesterol-enriched diet plus L-arginine (L-arginine) or plus L-NAME (L-NAME) in drinking water for 12 weeks. Values are mean 9 S.E.M. *, PB 0.05.
